The biochemistry and biology of the atypical chemokine receptors
- PMID: 22698181
- DOI: 10.1016/j.imlet.2012.04.004
The biochemistry and biology of the atypical chemokine receptors
Abstract
A subset of chemokine receptors, initially called "silent" on the basis of their apparent failure to activate conventional signalling events, has recently attracted growing interest due to their ability to internalize, degrade, or transport ligands and thus modify gradients and create functional chemokine patterns in tissues. These receptors recognize distinct and complementary sets of ligands with high affinity, are strategically expressed in different cellular contexts, and lack structural determinants supporting Gα(i) activation, a key signalling event in cell migration. This is in keeping with the hypothesis that they have evolved to fulfil fundamentally different functions to the classical signalling chemokine receptors. Based on these considerations, these receptors (D6, Duffy antigen receptor for chemokines (DARC), CCX-CKR1 and CXCR7) are now collectively considered as an emerging class of 'atypical' chemokine receptors. In this article, we review the biochemistry and biology of this emerging chemokine receptor subfamily.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
-
Atypical chemokine receptors in inflammatory disease.Curr Mol Med. 2009 Feb;9(1):86-93. doi: 10.2174/156652409787314480. Curr Mol Med. 2009. PMID: 19199944 Review.
-
D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes.Eur J Immunol. 2009 Feb;39(2):342-51. doi: 10.1002/eji.200838858. Eur J Immunol. 2009. PMID: 19130487 Review.
-
Contribution of Duffy antigen to chemokine function.Cytokine Growth Factor Rev. 2005 Dec;16(6):687-94. doi: 10.1016/j.cytogfr.2005.05.011. Epub 2005 Jul 27. Cytokine Growth Factor Rev. 2005. PMID: 16054417 Review.
-
Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.Cytokine Growth Factor Rev. 2005 Dec;16(6):679-86. doi: 10.1016/j.cytogfr.2005.05.003. Epub 2005 Jul 5. Cytokine Growth Factor Rev. 2005. PMID: 15996892 Review.
-
Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines.Eur J Immunol. 2006 Jul;36(7):1659-61. doi: 10.1002/eji.200636327. Eur J Immunol. 2006. PMID: 16791884
Cited by
-
CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment.Front Oncol. 2021 Apr 15;11:591386. doi: 10.3389/fonc.2021.591386. eCollection 2021. Front Oncol. 2021. PMID: 33937018 Free PMC article. Review.
-
Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.J Leukoc Biol. 2016 Jun;99(6):851-5. doi: 10.1189/jlb.1MR1015-457R. Epub 2015 Dec 29. J Leukoc Biol. 2016. PMID: 26715684 Free PMC article. Review.
-
CXCR7: a β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2.Cell Biosci. 2020 Nov 23;10(1):134. doi: 10.1186/s13578-020-00497-x. Cell Biosci. 2020. PMID: 33292475 Free PMC article.
-
The CXCL12/CXCR4/CXCR7 ligand-receptor system regulates neuro-glio-vascular interactions and vessel growth during human brain development.J Inherit Metab Dis. 2013 May;36(3):455-66. doi: 10.1007/s10545-012-9574-y. Epub 2013 Jan 23. J Inherit Metab Dis. 2013. PMID: 23344887
-
Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2.J Invest Dermatol. 2017 Jan;137(1):85-94. doi: 10.1016/j.jid.2016.07.039. Epub 2016 Aug 26. J Invest Dermatol. 2017. PMID: 27568525 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases